Advicenne

PA:ALDVI France Biotechnology
Market Cap
$28.53 Million
€27.79 Million EUR
Market Cap Rank
#26540 Global
#255 in France
Share Price
€1.91
Change (1 day)
+3.24%
52-Week Range
€1.13 - €2.19
All Time High
€15.27
About

Advicenne S.A., a specialty pharmaceutical company, develops, commercializes, and markets treatments for rare renal diseases in France and internationally. It offers Sibnayal for the treatment of metabolic disorders, distal renal tubular acidosis, and cystinuria. The company also distributes Likozam, a formulation of clobazam for the treatment of short-term symptomatic of severe, disabling, or co… Read more

Advicenne (ALDVI) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of December 2024: -0.099x

Based on the latest financial reports, Advicenne (ALDVI) has a cash flow conversion efficiency ratio of -0.099x as of December 2024.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.89 Million) by net assets (€-19.07 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Advicenne - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Advicenne's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Advicenne Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Advicenne ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Advicenne (2015–2024)

The table below shows the annual cash flow conversion efficiency of Advicenne from 2015 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €-19.07 Million €-762.00K 0.040x -92.01%
2023-12-31 €-11.97 Million €-5.99 Million 0.500x -41.93%
2022-12-31 €-10.62 Million €-9.15 Million 0.862x +102.13%
2021-12-31 €309.00K €-12.53 Million -40.534x -1034.15%
2020-12-31 €3.27 Million €-11.69 Million -3.574x -538.39%
2019-12-31 €16.92 Million €-9.47 Million -0.560x -62.93%
2018-12-31 €29.63 Million €-10.18 Million -0.344x -98.49%
2017-12-31 €33.51 Million €-5.80 Million -0.173x -1230.87%
2016-12-31 €-5.15 Million €67.00K -0.013x -100.81%
2015-12-31 €-1.67 Million €-2.69 Million 1.613x --